Current knowledge about the role of microRNAs (miRNAs) in tumor
glucose metabolism is growing
Balkhiyarova, Z.,
Luciano, R.,
Kaakinen, M.,
Ulrich, A.,
Shmeliov, A.,
Bianchi, M.,
Chioma, L.,
Dallapiccola, B.,
Prokopenko, I.,
Manco, M. (2022) relationship between obesity and impaired
glucose metabolism in children and adolescents. Genotyping of 42 SNPs
Shnayder, Natalia A.,
Grechkina, Violetta V.,
Trefilova, Vera V.,
Efremov, Ilya S.,
Dontceva, Evgenia A.,
Narodova, Ekaterina A.,
Petrova, Marina M.,
Soloveva, Irina A.,
Tepnadze, Liia E.,
Reznichenko, Polina A.,
Al-Zamil, Mustafa,
Altynbekova, Gulnara I.,
Strelnik, Anna I.,
Nasyrova, Regina F. (2023) to a cluster of
metabolic conditions such as abdominal obesity, high blood pressure, high blood
glucoseDobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) and cholinergic.
Metabolic disorders are the most severe adverse drug reactions (ADRs) and lead to cardiovascular
Tinkov, Alexey A.,
Gatiatulina, Eugenia R.,
Popova, Elizaveta V.,
Polyakova, Valentina S.,
Skalnaya, Anastasia A.,
Agletdinov, Eduard F.,
Nikonorov, Alexandr A.,
Skalny, Anatoly V. (2017) fat, respectively, for 1 month. Serum lipid spectrum, apolipoproteins,
glucose, insulin, adiponectin
Yunusbaeva, Milyausha,
Borodina, Liliya,
Terentyeva, Darya,
Bogdanova, Anna,
Zakirova, Aigul,
Bulatov, Shamil,
Altinbaev, Radick,
Bilalov, Fanil,
Yunusbayev, Bayazit (2024) of the gut microbiome in tuberculosis (TB) patients. However, these studies did not explore the
metabolicAbstract—Type 2 diabetes is a complex and multifactorial
metabolic disorder. The frequency of type
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) with energy
metabolism pathways in diabetic mouse heart. Further data showed that AMPK pathway was impaired